| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.
|
Diabetologia
|
2003
|
4.33
|
|
2
|
Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study Group.
|
BMJ
|
1997
|
3.33
|
|
3
|
The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus.
|
Diabet Med
|
1999
|
3.26
|
|
4
|
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.
|
Lancet
|
2004
|
2.90
|
|
5
|
Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase.
|
Diabetologia
|
2012
|
2.85
|
|
6
|
Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.
|
Diabetologia
|
2008
|
2.51
|
|
7
|
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
|
Diabetes
|
1998
|
2.38
|
|
8
|
The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus.
|
Diabet Med
|
1999
|
2.31
|
|
9
|
Children with type-1 diabetes and their unaffected siblings have fewer symptoms of asthma.
|
Lancet
|
1999
|
2.26
|
|
10
|
A novel micro-assay for insulin autoantibodies.
|
J Autoimmun
|
1997
|
1.90
|
|
11
|
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis.
|
Tissue Antigens
|
2007
|
1.77
|
|
12
|
Capillary whole blood measurement of islet autoantibodies.
|
Diabetes Care
|
1999
|
1.66
|
|
13
|
Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus.
|
BMJ
|
1997
|
1.61
|
|
14
|
Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies.
|
Diabetologia
|
2010
|
1.57
|
|
15
|
Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
|
Lancet
|
1990
|
1.54
|
|
16
|
HLA class II typing of whole genome amplified mouth swab DNA.
|
Tissue Antigens
|
2000
|
1.37
|
|
17
|
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
|
Diabetologia
|
1995
|
1.31
|
|
18
|
Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study Group.
|
Diabetologia
|
1994
|
1.30
|
|
19
|
Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives.
|
Diabetologia
|
2008
|
1.25
|
|
20
|
Safety of high-dose nicotinamide: a review.
|
Diabetologia
|
2000
|
1.22
|
|
21
|
Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2.
|
Diabetologia
|
2008
|
1.22
|
|
22
|
Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
|
Diabetes Care
|
1999
|
1.13
|
|
23
|
IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
|
J Immunol
|
1998
|
1.12
|
|
24
|
Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases.
|
J Rheumatol
|
1986
|
1.10
|
|
25
|
Trial of ganglioside GM1 in acute stroke.
|
J Neurol Neurosurg Psychiatry
|
1988
|
1.06
|
|
26
|
Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: a cohort study.
|
Diabet Med
|
2004
|
1.04
|
|
27
|
Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives.
|
Diabetologia
|
2006
|
1.03
|
|
28
|
Update on major trials for the prevention of type 1 diabetes mellitus: the American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT).
|
J Pediatr Endocrinol Metab
|
2001
|
1.01
|
|
29
|
GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
|
Diabetologia
|
2007
|
0.99
|
|
30
|
An association analysis of the HLA gene region in latent autoimmune diabetes in adults.
|
Diabetologia
|
2006
|
0.95
|
|
31
|
Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen.
|
J Autoimmun
|
1994
|
0.92
|
|
32
|
'Insulin autoantibody affinity measurement using a single concentration of unlabelled insulin competitor discriminates risk in relatives of patients with type 1 diabetes.
|
Clin Exp Immunol
|
2012
|
0.91
|
|
33
|
A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetes.
|
Diabetologia
|
2001
|
0.91
|
|
34
|
Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
|
Diabetologia
|
2002
|
0.90
|
|
35
|
The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence.
|
Diabetologia
|
2003
|
0.90
|
|
36
|
GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
|
Diabet Med
|
2006
|
0.89
|
|
37
|
Worth the wait: type 1 diabetes prospective birth cohort studies enter adolescence.
|
Diabetologia
|
2012
|
0.86
|
|
38
|
Evaluation of a high-throughput second antibody radiobinding assay for measuring IgA antibodies to human tissue transglutaminase.
|
J Immunol Methods
|
1999
|
0.85
|
|
39
|
Combined analysis of IDDM-related autoantibodies in healthy schoolchildren.
|
Lancet
|
1994
|
0.85
|
|
40
|
Diabetes in the parents of children with Type I diabetes.
|
Diabetologia
|
2002
|
0.84
|
|
41
|
Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.
|
Diabet Med
|
2005
|
0.84
|
|
42
|
Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. The ICARUS Group. Islet Cell Antibody Register User's Study.
|
Diabetes Care
|
1993
|
0.83
|
|
43
|
An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes.
|
Diabetologia
|
2011
|
0.83
|
|
44
|
The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.
|
Diabetes Care
|
2001
|
0.83
|
|
45
|
Measurement of nicotinamide and N-methyl-2-pyridone-5-carboxamide in plasma by high performance liquid chromatography.
|
Biomed Chromatogr
|
1999
|
0.83
|
|
46
|
Three generations of autoimmune diabetes: an extended family study.
|
Diabetologia
|
2003
|
0.82
|
|
47
|
Islet autoantibodies and their use in predicting insulin-dependent diabetes.
|
Acta Diabetol
|
1997
|
0.82
|
|
48
|
Proinsulin-specific autoantibodies are relatively infrequent in young offspring with pre-type 1 diabetes.
|
Diabetes Care
|
2001
|
0.82
|
|
49
|
Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.
|
Diabetologia
|
2008
|
0.81
|
|
50
|
Strategies to prevent type 1 diabetes.
|
Diabetes Obes Metab
|
2009
|
0.81
|
|
51
|
Prevention of type 1 diabetes.
|
Br Med Bull
|
2011
|
0.80
|
|
52
|
Early T-cell defects in pre-type 1 diabetes.
|
Acta Diabetol
|
1992
|
0.80
|
|
53
|
Soluble L-selectin levels in type I diabetes mellitus: a surrogate marker for disease activity?
|
Immunology
|
2000
|
0.80
|
|
54
|
Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetes.
|
J Autoimmun
|
1999
|
0.79
|
|
55
|
Low interleukin-2 receptor levels in serum of patients with insulin-dependent diabetes.
|
Clin Investig
|
1994
|
0.79
|
|
56
|
Coxsackie B virus and postviral fatigue syndrome.
|
BMJ
|
1991
|
0.78
|
|
57
|
Reanalysis of twin studies suggests that diabetes is mainly genetic.
|
BMJ
|
2001
|
0.78
|
|
58
|
Can we prevent IDDM?
|
Diabetes Care
|
1994
|
0.76
|
|
59
|
Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
|
Lancet
|
1994
|
0.76
|
|
60
|
Eczema and Type 1 diabetes.
|
Diabet Med
|
2002
|
0.75
|
|
61
|
-to: Pani MA, Van Autreve J, Van der Auwera BJ, Gorus FK, Badenhoop K (2002) Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type 1 diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules. Diabetologia 45:1340-1343.
|
Diabetologia
|
2003
|
0.75
|
|
62
|
Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease.
|
Diabetologia
|
1994
|
0.75
|
|
63
|
Family studies of insulin-dependent diabetes: the UK experience.
|
Adv Exp Med Biol
|
1988
|
0.75
|
|
64
|
Genetics of diabetes. Lessons from family studies.
|
Baillieres Clin Endocrinol Metab
|
1991
|
0.75
|